Skip to main content

Intubation Science Selects ADM Tronics to Finalize Development and Manufacture of Breakthrough Intubation System

Northvale, NJ, Oct. 05, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ADM Tronics Unlimited, Inc. (OTCQB – ADMT) announced that Intubation Science, Inc. (“ISI”) has selected ADMT to finalize engineering development and manufacture of the Light Speed Intubator-Imaging Stylet System (the “LSI System”).  The LSI System is a novel intubation system developed and multi-patented by ISI for US and international medical markets.

The LSI System is a single-use, disposable, sterilized device intended for examination and visualization of a patient’s upper airway throughout intubation, thus aiding safer placement of endotracheal tubes.

The LSI System is intended for use in both hospital and pulmonary outpatient surgical centers and provides rapid intubation under optical guidance, for placement of an endotracheal tube. 

It is intended to be used by physicians and surgeons, and by nursing and technical staff, under their direction and guidance.  Additional use scenarios can include emergency utilization by EMTs, medics, and first responders.  In addition to such acute use situations, it can be deployed for chronic intubation applications in ICUs, long-term care facilities (nursing homes) as well as in acute/chronic applications such as in LTACHs (long-term acute care hospitals).

“The LSI System is a significant breakthrough in intubation scenarios that has the potential to save pulmonary-impaired patients from critical injury and death, especially during this time of COVID with its high incidence of required intubations,” stated Jerry Katzman, MD, President of ISI.  “We are excited to be working with ADMT to finalize this important technology for the worldwide medical markets.”

The LSI System requires additional engineering development for volume manufacturing and regulatory compliance.  ADMT will provide the engineering activities for development of efficient manufacturing design and regulatory requirements for volume production of the LSI System in ADMT’s FDA-Registered Medical Device Manufacturing Facility in Northvale, NJ.  

ADMT welcomes inquiries for its medical device services via the ADMT website – www.admtronics.com.

To receive email updates directly from ADMT, fill in the form at the bottom of the page at this link: https://admtronics.com/investor-relations/ 

About ADMT

ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products.  Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house.  ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and Eco-Friendly, Water-Based Formulations.  The Company’s headquarters, laboratories, FDA-Registered medical device, and manufacturing operations are in Northvale, NJ.  ADMT’s multi-disciplinary team of engineers, researchers, and technologists utilize advanced technology infrastructure, such as rapid 3-D prototyping, precision instrumentation and specialized software and peripherals, for research, development, and commercialization of diversified technologies. Additional information is available on the Company’s website – admtronics.com.
 
Except for historical information contained herein, the matters set forth in this news release are “forward-looking” statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance.  Although ADMT believes the expectations reflected in such forward-looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations.  Factors that could contribute to such differences include those described from time to time in ADMT’s SEC filings, news releases, and other communications. The Company assumes no obligation to update the information contained in this news release.

Andre DiMino

201-767-6040

andre@admtronics.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.